Sevelamer: all 51 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Calcium-Phosphorus Regulation Therapy on Heart Valve DiseaseRecruitingNCT06660524Phase 4
- Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In ChinaCompletedNCT03001011Phase 3Results posted
- Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)CompletedNCT02127125Phase 2Results posted
- Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)CompletedNCT02124759Phase 2Results posted
- An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney DiseaseCompletedNCT01574326Phase 2Results posted
- Sevelamer for Reducing Endotoxemia and Immune ActivationCompletedNCT01543958Phase 2Results posted
- The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET ScanTerminatedNCT01238588Not applicableResults posted
- Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedNCT01191762Phase 3Results posted
- FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseCompletedNCT00999037Not applicableResults posted
- The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy VolunteersCompletedNCT00925704Phase 1Results posted
- Study of Phosphate Levels in Patients With Chronic Kidney DiseaseCompletedNCT00824460Phase 2Results posted
- A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKDCompletedNCT00785629Not applicableResults posted
- GLP-1-mediated Gluco-metabolic Effects of Bile Acid SequestrationCompletedNCT03739268Not applicable
- The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4Status unknownNCT03596749Phase 3
- Different Effects of Non-calcium Phosphate Binders on Serum CalciumCompletedNCT03451019Phase 4
- DS2330b Alone and With Sevelamer in Patients on Chronic HemodialysisCompletedNCT03305471Phase 1
- Hyperphosphatemia in Children With Chronic Kidney DiseaseStatus unknownNCT03202407Phase 3
- Phosphate in Blood Pressure RegulationCompletedNCT02822131Not applicable
- Effect of Bile Acid Secretion and Sequestration on GLP-1 SecretionCompletedNCT02445508Not applicable
- A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722CompletedNCT02346890Phase 1
- An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD PatientsCompletedNCT02332811Phase 3
- Effect of Sevelamer on P-cresol Levels in CKDStatus unknownNCT02199444Phase 3
- Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut MicrobiotaCompletedNCT02061124Not applicable
- Sevelamer in Proteinuric CKDCompletedNCT01968759Phase 2
- Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis PatientsCompletedNCT01755078Phase 4
- Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on HemodialysisCompletedNCT01736150Phase 3
- The Effects of Sevelamer Carbonate on Diabetic NephropathyCompletedNCT01493050Phase 2
- Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseCompletedNCT01308242Early Phase 1
- Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4TerminatedNCT01277497Phase 4
- Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder.CompletedNCT01231438Phase 2
- FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney DiseaseCompletedNCT01220843Phase 3
- Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)CompletedNCT01135615Phase 4
- Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal DiseaseCompletedNCT01049815Not applicable
- Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed PatientsTerminatedNCT01011699Phase 3
- Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic NephropathyCompletedNCT00967629Phase 1
- Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)WithdrawnNCT00837655Not applicable
- A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTerminatedNCT00833768Phase 3
- Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney DiseaseCompletedNCT00806481Phase 2
- Sevelamer Hydrochloride in Peritoneal Dialysis PatientsCompletedNCT00745589Not applicable
- Reduce Cardiovascular Calcifications to Reduce QT Interval in DialysisCompletedNCT00710788Not applicable
- Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on HemodialysisCompletedNCT00704678Phase 2
- A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate HypercholesteremiaCompletedNCT00690937Phase 2
- An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On DialysisCompletedNCT00681941Phase 3
- Regulation of Bone Formation in Renal OsteodystrophyCompletedNCT00560300Phase 2
- Sevelamer, Fetuin-A and Endothelial Dysfunction in CKDCompletedNCT00486772Phase 4
- Cross-Over Study of Sevelamer Hydrochloride and Sevelamer CarbonateCompletedNCT00440648Phase 2
- Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium AcetateWithdrawnNCT00364000Not applicable
- Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer DosingCompletedNCT00324376Phase 2
- Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on HemodialysisCompletedNCT00268957Phase 3
- Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis PatientsCompletedNCT00267514Phase 3
- Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal DialysisCompletedNCT00196755Phase 3